WASHINGTON — SGLT2 inhibitors can reduce the need for urate-lowering and flare therapies, and lower the odds of gout-centric medical visits, in patients with gout alongside type 2 diabetes, according to a speaker at ACR Convergence 2024.“Although SGLT2 inhibitors were initially approved for diabetes, of course, now we’ve discovered many additional benefits — both
SAN ANTONIO — Semaglutide 2.4 mg was associated with reduced year-over-year health care costs, up to $6,500, among patients with overweight or obesity and heart…
There has been little research on optimal treatments for pediatric patients with pulmonary arterial hypertension, but the Kids MoD PAH Trial is expected to change…
Having GERD, diabetes or osteoporosis in addition to COPD heightened the likelihood for exacerbations, ED visits and hospitalizations, according to results published in Chronic Obstructive…
The International Olympic Committee’s (IOC) consensus statement on ‘methods for recording and reporting of epidemiological data on injury and illness in sport’ recommended standardising methods…
nclear. Objectives: This study aimed to evaluate bone metabolism in CRPS using TPBS and bone serum markers. Methods: A deep learning model for automated segmentation…
A podcast hosted by Shikha Jain, MD, FACP, covering modern day health care in an ever-evolving world. Watch 2024 episodes on Healio today.
In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses the mounting threat of cyberattacks on health care organizations and how employees are often…
